Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2022 Feb 24;226(6):864–866. doi: 10.1016/j.ajog.2022.02.028

Impact of the COVID-19 pandemic on the incidence of prematurity: critical role of gestational age and environment

Barry Weinberger 1, Jasmin Divers 2, Deborah Campbell 3, Steven Ham 4, Courtney Juliano 5, Dalibor Kurepa 6, Edmund Lagamma 7, Pradeep Mally 8, Suhas Nafday 9, Sheri Nemerofsky 10, Shanthy Sridhar 11, Kim Williams 12, Nazeeh Hanna 13
PMCID: PMC8919934  PMID: 35218696

Objective

Data on the incidence of prematurity during the COVID-19 pandemic are contradictory, with some reports showing decreased preterm births and others showing no effect.1 , 2 We propose that multiple biologic effects of SARS-CoV-2 infection and environmental changes during the pandemic exert competing effects on the preterm birth rate.

SARS-CoV-2 infection may increase preterm births by increasing preeclampsia and medically indicated preterm births,3 but its effects on spontaneous preterm births are unknown. Infection is the most commonly identified etiologic contributor to spontaneous preterm births at <28 weeks’ gestation.4 Our preliminary data demonstrated that SARS-CoV-2 placental infection increases the expression of placenta-specific microRNA 519c, which protects against infection-induced preterm birth.5 Furthermore, environmental effects of the COVID-19 pandemic (lockdowns, quarantine, decreased travel) may decrease pathogen exposures that can trigger infection-induced preterm birth.6 Therefore, the effects of the COVID-19 pandemic on the rates of prematurity likely reflect a balance between increased preeclampsia-induced preterm births and decreased infection-induced spontaneous preterm births.

New York was the first epicenter of the COVID-19 pandemic in the United States. The prevalence of SARS-CoV-2 infection exploded in March 2020, with a surge in the urban center. Lockdowns were initiated in all jurisdictions by mid-March. We compared the incidence of extreme prematurity (with and without preeclampsia) in 2020 with that of 2019 in a large cross-sectional study of hospitals in the New York City area.

Study Design

Data were collected from urban medical centers (New York University Tisch Hospital, Lenox Hill Hospital, Montefiore Medical Center, Mount Sinai Hospital) and suburban medical centers (New York University Langone Hospital—Long Island, Long Island Jewish Medical Center, North Shore University Hospital, Westchester Medical Center, and Stony Brook University Hospital) in New York. Rates of prematurity with and without preeclampsia were compared using the inverted skew-corrected score test for binomial distributions and Poisson regression.

Results

Total deliveries decreased from 63,327 in 2019 to 62,020 in 2020, with a SARS-CoV-2 positivity rate of 30.1 per 1000 (Table 1 ). Extreme prematurity (<28 weeks’ gestation) decreased from 5.6 to 4.7 per 1000 deliveries in 2020 (P<.0001), but the rate of moderate prematurity (28–35 weeks’ gestation) did not change. Preeclampsia increased in 2020, from 123.9 to 179.9 per 1000 in mothers who delivered at <28 weeks’ gestation.

Table 1.

Number and rates of preterm deliveries in 2019 and 2020

Variables 2019
2020
Difference (95% CI) P value
N Rate/1000 N Rate/1000
Deliveries 63,327 62,020 −1307 .0002
Delivery <35 wk 2255 35.6 2153 34.7 −0.9 (−1.9 to 0.1) .08
Delivery 28–35 wk 1900 30.0 1864 30.1 0.1 (−0.9 to 1.0) .9
Delivery <28 wk 355 5.6 289 4.7 −0.9 (−1.3 to −0.6) <.0001
 With preeclampsia 44 123.9 52 179.9 56.0 (28.0–83.0) <.0008
COVID-19 positive 1870 30.15

CI, confidence interval.

Weinberger.Impact of the COVID-19 pandemic on the incidence of prematurity. Am J Obstet Gynecol 2022.

At the suburban sites, overall prematurity dropped significantly (33.9 to 30.9/1000, P=.0001), primarily driven by decreased rates of extreme prematurity (3.5 to 2.5/1000, P<.0001). In contrast, at urban sites, total and extreme prematurity did not significantly decrease, and moderate prematurity increased (31.1 to 32.6/1000, P=.03). The rates of SARS-CoV-2 positivity were significantly higher in urban than in suburban sites (40.2 vs 18.4/1000, P<.0001) (Table 2 ).

Table 2.

Number and rate of preterm deliveries at urban and suburban hospitals

Variables Urban
2019
2020
Difference (95% CI) P value
N Rate/1000 N Rate/1000
Total deliveries 35,466 33,471
Delivery <35 wk 1311 37.0 1269 37.9 0.9 (−0.5 to 2.4) .2
Delivery 28–35 wk 1103 31.1 1091 32.6 1.5 (0.2–2.8) .03
Delivery <28 wk 208 5.9 178 5.3 −0.5 (−1.1 to 0.0) .06
 With preeclampsia 21 101.0 28 157.3 56.3 (22.2–88.6) .001
COVID-19 positive 1344 40.2
Suburban
Total deliveries 27,861 28,549
Delivery <35 wk 944 33.9 884 30.9 −2.9 (−4.4 to −1.5) .0001
Delivery 28–35 wk 847 30.4 812 28.4 −2.0 (−3.4 to −0.6) .06
Delivery <28 wk 97 3.5 72 2.5 −1.4 (−2.0 to −0.8) <.0001
 With preeclampsia 23 156.5 24 216.2 59.8 (11.5–105.7) .01163
COVID-19 positive 526 18.4

CI, confidence interval.

Weinberger. Impact of the COVID-19 pandemicon the incidence of prematurity. Am J Obstet Gynecol 2022.

Conclusion

In 2020, the COVID-19 pandemic in New York was associated with an overall decreased rate of extreme preterm births (<28 weeks’ gestation) despite an increased rate of preeclampsia. This is consistent with the fact that extreme preterm births usually occur spontaneously secondary to infection. Decreased intrapartum infection was likely related to both the environmental effects of lockdowns and possible biologic effects of SARS-CoV-2 infection on the placenta. In contrast, the rates of moderate prematurity (>28 weeks’ gestation) did not decrease. This is most likely related to the relative impact of increased preeclampsia and other medical indications for preterm delivery. Conflicting results in earlier reports may be related to the diversity in the gestational ages and the contributing etiologic factors for preterm birth in the studied population.

The effects of the pandemic in New York were different in urban and suburban populations. Total prematurity decreased at suburban sites, driven by significant decreases in extreme prematurity. In contrast, at urban sites, total and extreme prematurity remained unchanged, and moderate prematurity increased. It is possible that lockdowns were less effective in the urban locations, as demonstrated by the increased prevalence of COVID-19 infection. Our findings highlight the importance of providing socioeconomic data in reports on the population effects of the pandemic.

Footnotes

The authors report no conflict of interest.

This work was supported partially by the the Eunice Kennedy ShriverNational Institute of Child Health and Human Development, under grant number R21 HD100653-01.

References

  • 1.Harvey E.M., McNeer E., McDonald M.F., et al. Association of preterm birth rate with COVID-19 statewide stay-at-home orders in Tennessee. JAMA Pediatr. 2021;175:635–637. doi: 10.1001/jamapediatrics.2020.6512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Handley S.C., Mullin A.M., Elovitz M.A., et al. Changes in preterm birth phenotypes and stillbirth at 2 Philadelphia hospitals during the SARS-CoV-2 pandemic, March-June 2020. JAMA. 2021;325:87–89. doi: 10.1001/jama.2020.20991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Conde-Agudelo A., Romero R. SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022;226:68–89.e3. doi: 10.1016/j.ajog.2021.07.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Goldenberg R.L., Culhane J.F., Iams J.D., Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371:75–84. doi: 10.1016/S0140-6736(08)60074-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Tiozzo C., Bustoros M., Lin X., et al. Placental extracellular vesicles-associated microRNA-519c mediates endotoxin adaptation in pregnancy. Am J Obstet Gynecol. 2021;225:681.e1–681.e20. doi: 10.1016/j.ajog.2021.06.075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Racicot K., Mor G. Risks associated with viral infections during pregnancy. J Clin Invest. 2017;127:1591–1599. doi: 10.1172/JCI87490. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Obstetrics and Gynecology are provided here courtesy of Elsevier

RESOURCES